Sino Biopharmaceutical
1177.HK
#2048
Rank
S$10.39 B
Marketcap
$0.57
Share price
0.61%
Change (1 day)
-13.71%
Change (1 year)
Sino Biopharmaceutical is a company based on Hong Kong that does R&D, production and sales of pharmaceuticals.

Revenue for Sino Biopharmaceutical (1177.HK)

Revenue in 2021 (TTM): S$5.18 Billion

According to Sino Biopharmaceutical's latest financial reports the company's current revenue (TTM ) is S$5.17 Billion. In 2020 the company made a revenue of S$4.54 Billion a decrease over the revenue in the year 2019 that were of S$4.72 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sino Biopharmaceutical from 2011 to 2021

Annual revenue

Year Revenue Change
2021 (TTM) S$5.18 B14.09%
2020 S$4.54 B-3.78%
2019 S$4.72 B10.41%
2018 S$4.27 B44.83%
2017 S$2.95 B-4.16%
2016 S$3.08 B12.72%
2015 S$2.73 B29.28%
2014 S$2.11 B32.13%
2013 S$1.60 B22.82%
2012 S$1.30 B37.98%
2011 S$0.94 B